Vertex Pharma (VRTX) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $521.12 -1.47%
Revenue Growth %: +10.7%
Financial Fact:
Loss before provision for income taxes: -39.03M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: +10.7%
Financial Fact:
Loss before provision for income taxes: -39.03M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q1 EPS of ($0.62), $0.13 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $138.5 million versus the consensus estimate of $142.38 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- American Eagle Outfitters (AEO) Tops Q2 EPS by 57c
- Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
